“The existing scenario has exposed some structural weaknesses while in the EU’s medicines provide chain and also a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides stated. She suggested that provide chain issues be tackled in an EU pharmaceutical method anticipated being introduced by the top from the https://www.rilife.co/advanced-pharmaceutical-ingredients-importers-exporter-suppliers-in-india-2/